<DOC>
	<DOCNO>NCT00664846</DOCNO>
	<brief_summary>The purpose study analyse cross-section data secondary stroke prevention China carry standard medical management include medicine interactive education program , evaluate efficacy safety standard medical management secondary stroke prevention .</brief_summary>
	<brief_title>Standard Medical Management Secondary Prevention Ischemic Stroke China</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1 . Ischemic cerebral infarction TIA within 30 day . 2 . Aged 18 year old . 3 . Hospitalized . 4 . Cranial CT MRI scan exclude intracranial hemorrhagic diseases 5 . Stable clinical neurological condition . 6 . A Modified Rankin score le 4 enrollment 7 . Informed consent obtain . Patients exclude entry criterion list meet 1 . Documented stroke cause condition atherosclerosis , ie , surgical vascular intervention procedure . 2 . Severe comorbid unstable medical condition , ie , heart failure , respiratory failure renal failure , severe liver dysfunction , malignancy likelihood death within next 2 year 3 . Significant memory behavioural disorder , ie , Alzheimer disease , etc , daily care need . 4 . A Modified Rankin score 4 5 . Concurrent participation another clinical trial 6 . Pregnant 7 . Unable give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Prevention Therapy</keyword>
</DOC>